In vitroactivity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections | Zendy

Gregory G. Stone | Zendy; Patricia A. Bradford | Zendy; Katrina Yates | Zendy; Paul Newell | Zendy

Open Access

In vitroactivity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections

Author(s) -

Gregory G. Stone,

Patricia A. Bradford,

Katrina Yates,

Paul Newell

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw561

Subject(s) - ceftazidime/avibactam , ceftazidime , enterobacter cloacae , microbiology and biotechnology , avibactam , enterobacteriaceae , urinary system , proteus mirabilis , pseudomonas aeruginosa , broth microdilution , medicine , klebsiella pneumoniae , escherichia coli , biology , antibiotics , minimum inhibitory concentration , bacteria , biochemistry , genetics , gene

To evaluate the in vitro activity of ceftazidime/avibactam relative to comparator agents against Gram-negative isolates from a Phase 3 clinical trial programme for complicated urinary tract infections (RECAPTURE).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research